Simultaneous control of hyperglycemia and oxidative stress normalizes enhanced thrombin generation in type 1 diabetes

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 7, 2009, Pages 1228-1230

  Ceriello, Antonio ^a   Esposito, K ^b   Ihnat, M ^c   Zhang, J ^a   Giugliano, D ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ASCORBIC ACID; INSULIN; THROMBIN;

ADD ON THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

DIABETES MELLITUS, TYPE 1; HUMANS; HYPERGLYCEMIA; OXIDATIVE STRESS; THROMBIN;

EID: 67649502995     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03445.x     Document Type: Article

References (17)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
2. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-53.
3. Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol 2008; 51: 944-55.
4. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-75.
5. Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med 2007; 262: 157-72.
6. Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabetes Complications 2001; 15: 44-54.
7. Ceriello A. Coagulation activation in diabetes mellitus: The role of hyperglycaemia and therapeutic prospects. Diabetologia 1993; 36: 1119-25.
8. Iorio A, Orsini Federici M, Mourvaki E, Ferolla P, Piroddi M, Stabile A, Timi A, Celleno R, Massi Benedetti M. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients. Thromb Haemost 2007; 98: 635-41.
9. Ceriello A, Taboga C, Giacomello R, Falleti E, De Stasio G, Motz E, Lizzio S, Gonano F, Bartoli E. Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes 1994; 43: 430-2.
10. Boden G, Vaidyula VR, Homko C, Cheung P, Rao AK. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: Effects of insulin and glucose. J Clin Endocrinol Metab 2007; 92: 4352-8.
11. Vaidyula VR, Rao AK, Mozzoli M, Homko C, Cheung P, Boden G. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 2006; 55: 202-8.
12. Stegenga ME, van der Crabben SN, Levi M, de Vos AF, Tanck MW, Sauerwein HP, van der Poll T. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 2006; 55: 1807-12.
13. Lubos E, Handy DE, Loscalzo J. Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci 2008; 13: 5323-44.
14. Skrha J, Hodinár A, Kvasnicka J, HilgertováJ. Relationship of oxidative stress and fibrinolysis in diabetes mellitus. Diabet Med 1996; 13: 800-5.
15. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, Pirisi M, Falleti E, Bartoli E. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 1995; 44: 924-8.
16. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
17. Ceriello A, Ihnat MA, Thorpe JE. The 'Metabolic Memory': Is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 2009; 94: 410-15.